HCG Manavata Cancer Centre is Maharashtra's first NABH-accredited cancer hospital, trusted for quality and safety. It treats over 25,000 patients annually with advanced radiotherapy tech like TomoTherapy-H and Versa HD. Proton therapy for prostate cancer is led by Dr Shruti Kate, trained at Tata Memorial Hospital with expertise in genitourinary cancers. The centre’s clinical research institute is audited by the US FDA, assuring compliance with international standards, making it a reliable choice for Australian patients.